Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

NCT00524810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Pegylated liposomal doxorubicin
DRUG: Docetaxel

Sponsor

ARCAGY/ GINECO GROUP